Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
NTRA — Price & Forward EBITDA
Forward EBITDA (M)

Float Short %

2.45

Margin Of Safety %

-24

Put/Call OI Ratio

0.67

EPS Next Q Diff

-0.9

EPS Last/This Y

-0.37

EPS This/Next Y

1.18

Price

209.3

Target Price

258.8

Analyst Recom

1.33

Performance Q

-11.86

Upside

-125.8%

Beta

1.68

Ticker: NTRA




19 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-03-09NTRA205.111.140.3221640
2026-03-10NTRA198.811.151.1621465
2026-03-11NTRA196.51.150.0121511
2026-03-12NTRA190.31.000.2822947
2026-03-13NTRA190.311.000.3022947
2026-03-17NTRA198.540.880.3324275
2026-03-18NTRA197.620.8714.6024455
2026-03-19NTRA202.660.845.5724138
2026-03-20NTRA195.390.820.3723576
2026-03-23NTRA200.060.690.7516654
2026-03-24NTRA195.520.690.5616739
2026-03-25NTRA197.380.690.2216750
2026-03-26NTRA196.260.680.4416812
2026-03-27NTRA183.650.680.3216823
2026-03-30NTRA187.010.690.9316823
2026-03-31NTRA200.130.680.3816827
2026-04-01NTRA203.310.682.0616877
2026-04-02NTRA208.210.680.1516838
2026-04-06NTRA204.910.670.0417018
DateSymbolLatestP/C OIP/C VolTotal OI
19 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-03-09NTRA205.18-11.6101.7-1.87
2026-03-10NTRA198.95-11.6112.3-1.87
2026-03-11NTRA196.52-11.6109.4-1.87
2026-03-12NTRA190.33-11.6112.6-1.87
2026-03-13NTRA187.82-11.6109.5-1.87
2026-03-17NTRA198.40-11.6106.8-1.87
2026-03-18NTRA197.60-11.6108.1-1.87
2026-03-19NTRA202.69-11.6-15.1-1.87
2026-03-20NTRA195.28-11.62.1-1.87
2026-03-23NTRA200.04-11.6-15.0-1.87
2026-03-24NTRA194.68-11.6-0.6-1.87
2026-03-25NTRA197.22-11.6-12.1-1.87
2026-03-26NTRA196.15-11.6-6.4-1.87
2026-03-27NTRA182.61-11.611.2-1.87
2026-03-30NTRA186.84-11.6-14.6-1.87
2026-03-31NTRA200.00-12.1-28.0-1.89
2026-04-01NTRA203.22-12.1-12.7-1.89
2026-04-02NTRA208.13-12.1-15.0-1.89
2026-04-06NTRA204.91-12.1-4.0-1.89
2026-04-07NTRA209.30-12.1-14.2-1.89
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-03-09NTRA-11.160.632.43
2026-03-10NTRA-11.160.632.43
2026-03-11NTRA-11.260.632.22
2026-03-12NTRA-11.370.632.22
2026-03-13NTRA-11.370.632.22
2026-03-17NTRA-13.540.602.22
2026-03-18NTRA-13.540.602.22
2026-03-19NTRA-13.540.602.22
2026-03-20NTRA-12.990.602.22
2026-03-23NTRA-12.890.762.22
2026-03-24NTRA-12.890.762.22
2026-03-25NTRA-12.890.762.45
2026-03-26NTRA-12.890.762.45
2026-03-27NTRA-12.890.762.45
2026-03-30NTRA-12.890.762.45
2026-03-31NTRA-12.890.762.45
2026-04-01NTRA-12.890.762.45
2026-04-02NTRA-12.550.762.45
2026-04-06NTRA-12.680.762.45
2026-04-07NTRA-12.680.762.45
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

0.36

Avg. EPS Est. Current Quarter

-0.56

Avg. EPS Est. Next Quarter

-0.54

Insider Transactions

-12.68

Institutional Transactions

0.76

Beta

1.68

Average Sales Estimate Current Quarter

617

Average Sales Estimate Next Quarter

643

Fair Value

158.58

Quality Score

49

Growth Score

51

Sentiment Score

97

Actual DrawDown %

18.4

Max Drawdown 5-Year %

-77.7

Target Price

258.8

P/E

Forward P/E

PEG

P/S

12.86

P/B

17.07

P/Free Cash Flow

271.84

EPS

-1.54

Average EPS Est. Cur. Y​

-1.89

EPS Next Y. (Est.)

-0.71

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-9.03

Relative Volume

0.76

Return on Equity vs Sector %

-39.6

Return on Equity vs Industry %

-22.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.1

EBIT Estimation

-14.2
NTRA Healthcare
$209.27
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
12/20
Pullback
8/25
Volume
6/15
Valuation
10/20
TP/AR
4/10
Options
0/10
RSI
55.8
Range 1M
91.9%
Sup Dist
3.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
33 /100
WEAK
Momentum
5/25
Growth
20/30
Estimates
4/20
Inst/Vol
4/15
Options
0/10
EPS Yr
-19.7%
EPS NY
66.5%
52W%
62.1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🔴 SELL -5% upside
Quality
6/30
Valuation
1/30
Growth
15/25
Stability
8/10
LT Trend
2/5
Upside
-5%
Quality
49
MoS
-24%
Natera, Inc.
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 6135
Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.
NTRA

Latest News

Caricamento notizie per NTRA
stock quote shares NTRA – Natera, Inc. Stock Price stock today
news today NTRA – Natera, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NTRA – Natera, Inc. yahoo finance google finance
stock history NTRA – Natera, Inc. invest stock market
stock prices NTRA premarket after hours
ticker NTRA fair value insiders trading